ARPO Aerpio Pharmaceuticals Inc

DGAP-News: WATTY Gears Up For the Multiuser AR Experience, Presents WATTY Dance Battle AR Game

DGAP-News: WATTY / Key word(s): Miscellaneous
WATTY Gears Up For the Multiuser AR Experience, Presents WATTY Dance Battle AR Game (news with additional features)

05.03.2019 / 11:00
The issuer is solely responsible for the content of this announcement.


WATTY Gears Up For the Multiuser AR Experience, Presents WATTY Dance Battle AR Game

WATTY Remote Technology Allows the Real Time Multiuser AR: Users are Sharing the Same AR Experience Within Different Physical Surfaces and Surroundings

LONDON, UK / ACCESSWIRE / March 5, 2019 / , an IT company led by Gleb Braverman and Vlad Vodolazov, presents WATTY Multiuser AR technology, the one making "Kingsman" and "Star Wars" augmented reality meetings much, much closer.

WATTY tech allows a virtually infinite number of users to share the same AR experience, not sharing the common "real world" surface. AR can now be displayed by people thousands of kilometres apart: whether it be an AR game, online lecture, remote surgery demonstration, engineering stuff training, in-city open world AR, or an influencer solving daily AR brain-teaser sharing stories with the followers, WATTY Multiuser AR will help users get those live and seamlessly.

WATTY releases its Dance Battle pilot multiplayer game to demonstrate the multiuser AR technology. Starting off with the cross-play iOS/Android-compatible alpha version, WATTY Dance Battle users will be able to dance-challenge their friends or celebrities online, making music videos and sharing them across social media. Players will use their unique avatars, styled and clothed to fit the personality.

Shareable dancing battles with friends and celebs is the key game feature. Not only can one dance with buddies, but get access to online dancing with famous people - movie stars, musicians, politicians, and influencers.

WATTY CEO and co-founder Gleb Braverman is excited about the upcoming launch of Dance Battle:

"The technology behind WATTY Dance Battle is yet to reveal its potential. Not only we see WATTY Remote driving the AR gaming industry revolution. Unlike the newly released $3,500 Microsoft Hololens claiming to support the remote collaboration mode designed for corporate use only, WATTY use-cases include EdTech, HealthTech, AR conferences, social network and corporate plugins, streaming and live video enhancement, dating apps, trainings, lectures and numerous manufacturing applications. WATTY Multiuser complements multiple industries by addressing the fundamental issue of remote AR experience accessibility."

WATTY will release an alpha-version of the Dance Battle AR game as soon as early March, with the operable viral beta available mid-April.

CONTACT:

SOURCE: WATTY


Additional features:

Document:
Document title: WATTY Dance Battle AR Game


05.03.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


783613  05.03.2019 

fncls.ssp?fn=show_t_gif&application_id=783613&application_name=news&site_id=research_pool
EN
05/03/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aerpio Pharmaceuticals Inc

 PRESS RELEASE

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced it will join both the U.S. small cap Russell 2000® Index and broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective immediately after the U.S. market opens on June 24, 2022 according to a preliminary list of add...

 PRESS RELEASE

Aadi Bioscience to Present at the Jefferies Global Healthcare Conferen...

Aadi Bioscience to Present at the Jefferies Global Healthcare Conference LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced members of the Aadi senior management team will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY June 8-10, 2022. Founder, Chief Executive Officer and President, Neil Desai, Ph.D. is scheduled to present live during a fire...

 PRESS RELEASE

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor R...

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced the appointment of Marcy Graham to the new position of Senior Vice President, Investor Relations (IR) and Corporate Communications. “We are delighted to welcome Marcy to the team, as she brings extensive experience to ...

 PRESS RELEASE

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in ...

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting Target tumor reductions observed in advanced malignant PEComa patients harboring TSC1 or TSC2 inactivating alterations regardless of prior mTOR inhibitor exposure LOS ANGELES, May 26, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced presentat...

 PRESS RELEASE

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Co...

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., and senior members of Aadi’s executive team will participate virtually in the H.C. Wainwright Global Investment Conference, to be held in person and virtually May 23-26, 2022 in Mia...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch